Floré has released the first ever line of probiotics designed for a neurodiverse demographic.
The products have been specifically formulated using data from the company's research collaboration with Arizona State University, which looked into the use of customisable probiotics in those with autism spectrum disorder (ASD).
The nutraceutical line includes:
- Pathways Support: A functional probiotic designed to boost metabolic function and thiamine levels, while diminishing the presence of harmful bacteria in the gut and enhancing levels of the calming neurotransmitter, GABA
- Mood Support: This probiotic was formulated to manage mood and overall wellbeing in neurodiverse individuals. By enhancing gut health, the nutraceutical aims to improve focus, reduce irritability and stabilise mood variations
Each product comes in a pack of 30, and are suitable for those with dietary restrictions and sensitivities.
Floré's CEO, Craig Rouskey, commented: “Having seen the immensely positive impact our customised probiotics had on participants during the study, we set out to create products that could provide widespread support and improved well-being for anyone experiencing neurodiversity,”
“At Floré, we are continuously leveraging research to innovate new and cutting-edge solutions to not only improve physical health but also enhance the overall quality of life for so many around the world.”
The research initiative run by the company saw participants experience a significant reduction in gastrointestinal issues, with a further increase in microbiome diversity.
60% of individuals also experienced an overall improvement in symptoms of their ASD, highlighting the potential of probiotics for this segment of the population.
